Literature DB >> 19688963

Anthracycline extravasation: a comprehensive review of experimental and clinical treatments.

Seppo W Langer1, Maxwell Sehested, Peter Buhl Jensen.   

Abstract

An accidental extravasation of anthracycline-containing chemotherapy is a feared complication that may lead to necrosis and severe tissue destruction. For four decades, much effort has been done to prevent and treat this devastating condition. Savene has recently been proved to be very effective, and is the only approved treatment against anthracyline extravasation. It is thus now widely recommended. The present article represents a comprehensive review of, and historical insight to, the experimental and clinical studies of surgical and non-surgical treatments of extravasation during forty years of clinical anthracycline treatment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19688963     DOI: 10.1177/030089160909500301

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916


  5 in total

Review 1.  Extravasation of chemotherapy.

Authors:  Seppo W Langer
Journal:  Curr Oncol Rep       Date:  2010-07       Impact factor: 5.075

Review 2.  Overview, prevention and management of chemotherapy extravasation.

Authors:  Firas Y Kreidieh; Hiba A Moukadem; Nagi S El Saghir
Journal:  World J Clin Oncol       Date:  2016-02-10

Review 3.  Management of the extravasation of anti-neoplastic agents.

Authors:  J Boulanger; A Ducharme; A Dufour; S Fortier; K Almanric
Journal:  Support Care Cancer       Date:  2015-02-26       Impact factor: 3.603

4.  A Primer on the Acute Management of Intravenous Extravasation Injuries for the Plastic Surgeon.

Authors:  Connor Maly; Kenneth L Fan; Gary F Rogers; Benjamin Mitchell; June Amling; Kara Johnson; Laura Welch; Albert K Oh; Jerry W Chao
Journal:  Plast Reconstr Surg Glob Open       Date:  2018-04-19

Review 5.  Dexrazoxane for the treatment of chemotherapy-related side effects.

Authors:  Seppo W Langer
Journal:  Cancer Manag Res       Date:  2014-09-15       Impact factor: 3.989

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.